Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Pharmaceutical stocks came under pressure on Wednesday after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, raising concerns over the long-term outlook for one of the industry's biggest export markets.

Raccontata datimesofindia.indiatimes.comeconomictimes.indiatimes.comthehindubusinessline.comhindustantimes.comnewsbytesapp.comtheprint.in